Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma

Fusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor abla...

Full description

Bibliographic Details
Main Authors: Hayet Amalou, Bradford J. Wood
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Case Reports in Urology
Online Access:http://dx.doi.org/10.1155/2012/390912
id doaj-aed6aafcd0124545b6d4b82cf46de959
record_format Article
spelling doaj-aed6aafcd0124545b6d4b82cf46de9592020-11-24T23:06:35ZengHindawi LimitedCase Reports in Urology2090-696X2090-69782012-01-01201210.1155/2012/390912390912Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell CarcinomaHayet Amalou0Bradford J. Wood1Center for Interventional Oncology, NIH Clinical Center, National Institutes of Health, MSC 1182, Bethesda, MD 20892, USACenter for Interventional Oncology, NIH Clinical Center, National Institutes of Health, MSC 1182, Bethesda, MD 20892, USAFusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor ablation, in whom there is a desire to minimize or avoid nephrotoxic iodinated contrast exposure. EM tracking software merges and fuses different imaging modalities such as MRI, CT, and ultrasound and can also display the position of needles in real time in relation to preprocedure imaging, which may better define tumor targets than available intraoperative imaging. EM tracking was successfully used to ablate a poorly visualized renal tumor, through the combined use of CT, gadolinium-enhanced MR, and contrast-enhanced US imaging to localize the tumor.http://dx.doi.org/10.1155/2012/390912
collection DOAJ
language English
format Article
sources DOAJ
author Hayet Amalou
Bradford J. Wood
spellingShingle Hayet Amalou
Bradford J. Wood
Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
Case Reports in Urology
author_facet Hayet Amalou
Bradford J. Wood
author_sort Hayet Amalou
title Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
title_short Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
title_full Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
title_fullStr Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
title_full_unstemmed Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
title_sort multimodality fusion with mri, ct, and ultrasound contrast for ablation of renal cell carcinoma
publisher Hindawi Limited
series Case Reports in Urology
issn 2090-696X
2090-6978
publishDate 2012-01-01
description Fusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure. This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor ablation, in whom there is a desire to minimize or avoid nephrotoxic iodinated contrast exposure. EM tracking software merges and fuses different imaging modalities such as MRI, CT, and ultrasound and can also display the position of needles in real time in relation to preprocedure imaging, which may better define tumor targets than available intraoperative imaging. EM tracking was successfully used to ablate a poorly visualized renal tumor, through the combined use of CT, gadolinium-enhanced MR, and contrast-enhanced US imaging to localize the tumor.
url http://dx.doi.org/10.1155/2012/390912
work_keys_str_mv AT hayetamalou multimodalityfusionwithmrictandultrasoundcontrastforablationofrenalcellcarcinoma
AT bradfordjwood multimodalityfusionwithmrictandultrasoundcontrastforablationofrenalcellcarcinoma
_version_ 1725622261144092672